◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

COSCIENS Biopharma Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 1.5M 2.7M 1.5M 3.3M 1.9M
Operating Revenue 1.5M 2.7M 1.5M 3.3M 1.9M
Cost Of Revenue 862,000 1.8M 1.1M 1.3M 914,000
Gross Profit 621,000 974,000 443,000 2.0M 957,000
Selling General And Administration 2.1M 2.6M 2.9M 2.7M 3.0M
General And Administrative Expense 2.1M -- -- 2.7M 3.0M
Research And Development 527,000 690,000 1.1M 2.9M 2.8M
Operating Expense 2.6M 3.3M 4.1M 5.7M 5.8M
Operating Income -2.0M -2.4M -3.6M -3.6M -4.8M
EBIT -1.8M -2.7M -3.6M -5.6M -5.8M
Interest Expense 43,000 23,000 70,000 23,000 22,000
Interest Expense Non Operating 43,000 23,000 70,000 23,000 22,000
Interest Income 57,000 83,000 106,000 -- 210,000
Interest Income Non Operating 57,000 83,000 106,000 -- 210,000
Net Interest Income 14,000 60,000 36,000 418,000 188,000
Other Income Expense 174,000 -407,000 -74,000 -2.5M -1.2M
Other Non Operating Income Expenses 4,000 8,000 8,000 -291,000 21,000
Special Income Charges -316,000 -- -- -2.8M -1.5M
Write Off 76,000 -- -- -- 0.00
Gain On Sale Of Security 486,000 -415,000 -82,000 632,000 217,000
Pretax Income -1.8M -2.7M -3.7M -5.6M -5.9M
Tax Provision 0.00 1,000 0.00 1.1M -112,000
Tax Effect Of Unusual Items 0.00 -62,250 0.00 -324,900 -23,710
Net Income From Continuing And Discontinued Operation -1.8M -2.7M -3.7M -6.7M -5.8M
Net Income From Continuing Operation Net Minority Interest -1.8M -2.7M -3.7M -6.7M -5.8M
Net Income Including Noncontrolling Interests -1.8M -2.7M -3.7M -6.7M -5.8M
Net Income Common Stockholders -1.8M -2.7M -3.7M -6.7M -5.8M
Net Income -1.8M -2.7M -3.7M -6.7M -5.8M
EBITDA -1.5M -2.4M -3.3M -5.2M -5.4M
Normalized EBITDA -1.7M -2.0M -3.2M -3.1M -4.1M
Reconciled Depreciation 287,000 287,000 325,000 392,000 479,000
Basic EPS -0.57 -0.85 -1.16 -- -1.85
Diluted EPS -0.57 -0.85 -1.16 -- -1.85
Basic Average Shares 3.2M 3.2M 3.1M -- 3.1M
Diluted Average Shares 3.2M 3.2M 3.1M -- 3.1M
Total Unusual Items 170,000 -415,000 -82,000 -2.2M -1.2M
Total Unusual Items Excluding Goodwill 170,000 -415,000 -82,000 -2.2M -1.2M
Tax Rate For Calcs 0.00 0.15 0.00 0.15 0.02
Normalized Income -2.0M -2.3M -3.6M -4.9M -4.5M
Diluted NI Availto Com Stockholders -1.8M -2.7M -3.7M -6.7M -5.8M
Impairment Of Capital Assets 240,000 -- -- 2.8M 1.5M
Net Income Continuous Operations -1.8M -2.7M -3.7M -6.7M -5.8M
Net Non Operating Interest Income Expense 14,000 60,000 36,000 418,000 188,000
Other Gand A 2.1M -- -- -1.1M 3.0M
Reconciled Cost Of Revenue 862,000 1.8M 1.1M 1.3M 914,000
Total Expenses 3.5M 5.1M 5.1M 6.9M 6.7M
Total Operating Income As Reported -2.3M -2.4M -3.6M -6.4M -6.3M
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 8.5M 9.3M 13.8M 16.4M 20.0M
Cash Cash Equivalents And Short Term Investments 8.5M 9.3M 13.8M 16.4M 20.0M
Cash Financial -- -- -- 16.4M --
Accounts Receivable 1.6M 2.8M 1.9M 2.4M 1.9M
Receivables 1.6M 2.8M 1.9M 2.5M 2.0M
Inventory 1.8M 1.8M 2.5M 2.7M 3.3M
Prepaid Assets 1.5M 2.2M 2.0M 2.2M 2.6M
Other Current Assets 156,000 319,000 325,000 210,000 312,000
Current Assets 13.8M 16.5M 20.4M 24.0M 28.2M
Gross PPE 20.1M 20.9M 19.9M 20.1M 22.6M
Accumulated Depreciation -10.2M -10.0M -9.2M -9.1M -10.8M
Net PPE 9.9M 10.9M 10.7M 11.0M 11.8M
Goodwill And Other Intangible Assets -- -- -- 0.00 1.8M
Other Intangible Assets -- -- -- -- 1.8M
Other Non Current Assets 132,000 132,000 128,000 123,000 126,000
Total Non Current Assets 10.0M 11.1M 10.8M 11.1M 15.5M
Total Assets 23.9M 27.6M 31.1M 35.1M 43.8M
Current Debt And Capital Lease Obligation 212,000 209,000 253,000 271,000 405,000
Accounts Payable 1.0M 1.5M 2.9M 2.4M 2.4M
Payables 1.1M 1.6M 3.0M 2.5M 2.6M
Payables And Accrued Expenses 1.8M 2.6M 4.1M 4.2M 4.5M
Current Accrued Expenses 650,000 967,000 1.0M 1.7M 1.9M
Current Deferred Revenue 19,000 19,000 122,000 120,000 46,000
Other Current Liabilities 1.4M 1.9M 1.6M 1.6M 2.1M
Current Liabilities 4.0M 5.5M 7.1M 7.2M 8.2M
Long Term Debt And Capital Lease Obligation 2.0M 2.0M 2.0M 2.0M 1.2M
Long Term Capital Lease Obligation 2.0M 2.0M 2.0M 2.0M 1.2M
Total Non Current Liabilities Net Minority Interest 14.8M 14.9M 13.9M 14.7M 15.6M
Total Liabilities Net Minority Interest 18.8M 20.5M 21.0M 21.9M 23.8M
Common Stock 22.6M 22.6M 22.5M 22.5M 22.4M
Capital Stock 22.6M 22.6M 22.5M 22.5M 22.4M
Additional Paid In Capital 4.2M 4.2M 4.3M 4.3M 4.3M
Retained Earnings -19.0M -17.2M -14.7M -12.1M -5.2M
Gains Losses Not Affecting Retained Earnings -2.7M -2.5M -2.0M -1.5M -1.6M
Other Equity Adjustments -2.7M -2.5M -2.0M -1.5M -1.6M
Common Stock Equity 5.1M 7.1M 10.1M 13.2M 20.0M
Stockholders Equity 5.1M 7.1M 10.1M 13.2M 20.0M
Total Equity Gross Minority Interest 5.1M 7.1M 10.1M 13.2M 20.0M
Total Capitalization 5.1M 7.1M 10.1M 13.2M 20.0M
Net Tangible Assets 5.1M 7.1M 10.1M 13.2M 18.2M
Tangible Book Value 5.1M 7.1M 10.1M 13.2M 18.2M
Working Capital 9.9M 11.0M 13.3M 16.8M 20.1M
Invested Capital 5.1M 7.1M 10.1M 13.2M 20.0M
Total Debt 2.2M 2.3M 2.2M 2.3M 1.6M
Share Issued 3.2M 3.2M 3.1M 3.1M 3.1M
Ordinary Shares Number 3.2M 3.2M 3.1M 3.1M 3.1M
Assets Held For Sale Current 286,000 -- -- -- --
Buildings And Improvements 3.7M 3.7M 3.6M 3.6M 2.9M
Capital Lease Obligations 2.2M 2.3M 2.2M 2.3M 1.6M
Current Capital Lease Obligation 212,000 209,000 253,000 271,000 405,000
Current Deferred Liabilities 24,000 32,000 170,000 168,000 185,000
Current Provisions 329,000 228,000 240,000 385,000 504,000
Employee Benefits 11.8M 11.8M 11.0M 11.7M 12.5M
Finished Goods 361,000 658,000 197,000 299,000 312,000
Income Tax Payable 118,000 118,000 109,000 105,000 113,000
Leases 5.8M 6.0M 5.6M 5.6M 6.6M
Long Term Provisions -- 46,000 -- -- --
Machinery Furniture Equipment 261,000 264,000 221,000 376,000 730,000
Non Current Accounts Receivable -- -- -- -- 729,000
Non Current Deferred Assets -- -- -- 0.00 1.1M
Non Current Deferred Liabilities 1.0M 1.0M 930,000 914,000 1.9M
Non Current Deferred Revenue 1.0M 1.0M 930,000 914,000 1.9M
Non Current Deferred Taxes Assets -- -- -- 0.00 1.1M
Other Inventories -- 1.0M 1.8M 2.0M 2.4M
Other Properties 10.3M 11.0M 10.5M 10.5M 12.4M
Pensionand Other Post Retirement Benefit Plans Current 288,000 574,000 758,000 607,000 432,000
Properties 0.00 0.00 0.00 0.00 0.00
Raw Materials 660,000 780,000 666,000 737,000 898,000
Taxes Receivable 0.00 0.00 0.00 114,000 123,000
Total Tax Payable 98,000 98,000 159,000 130,000 173,000
Work In Process 738,000 383,000 1.6M 1.7M 2.1M
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -676,000 -4.4M -1.9M -3.0M -7.8M
Cash Flow From Continuing Operating Activities -676,000 -4.4M -1.9M -3.0M -7.8M
Depreciation And Amortization 287,000 287,000 325,000 392,000 479,000
Depreciation Amortization Depletion 287,000 287,000 325,000 392,000 479,000
Stock Based Compensation -21,000 -85,000 6,000 10,000 427,000
Deferred Tax 0.00 0.00 0.00 1.1M -112,000
Deferred Income Tax 0.00 0.00 0.00 1.1M -112,000
Change In Working Capital 951,000 -2.4M 1.3M 754,000 -4.1M
Changes In Account Receivables 1.7M -607,000 1.1M -- -978,000
Change In Receivables 1.7M -607,000 1.3M -- -978,000
Change In Inventory -59,000 767,000 -- -- -206,000
Change In Payables And Accrued Expense -927,000 -2.2M 238,000 -- -3.6M
Change In Other Working Capital -355,000 -172,000 -413,000 -- 359,000
Other Non Cash Items 22,000 29,000 1,000 -845,000 -16,000
Capital Expenditure -- -49,000 -615,000 -309,000 -131,000
Purchase Of PPE -- -49,000 -615,000 -309,000 -131,000
Net PPE Purchase And Sale 4,000 -48,000 -611,000 -309,000 -131,000
Sale Of Business 0.00 0.00 -- 0.00 0.00
Investing Cash Flow 4,000 -48,000 -615,000 -316,000 83,000
Cash Flow From Continuing Investing Activities 4,000 -48,000 -615,000 -316,000 83,000
Repayment Of Debt -85,000 -65,000 -200,000 -109,000 -114,000
Net Issuance Payments Of Debt -85,000 -65,000 -200,000 -109,000 -114,000
Financing Cash Flow -85,000 -107,000 -200,000 -202,000 -188,000
Cash Flow From Continuing Financing Activities -85,000 -107,000 -200,000 -202,000 -188,000
Effect Of Exchange Rate Changes -52,000 177,000 60,000 -88,000 78,000
Changes In Cash -757,000 -4.6M -2.7M -3.5M -7.9M
Beginning Cash Position 9.3M 13.8M 16.4M 20.0M 27.8M
End Cash Position 8.5M 9.3M 13.8M 16.4M 20.0M
Free Cash Flow -676,000 -4.5M -2.5M -3.3M -7.9M
Asset Impairment Charge 316,000 -- -- 2.8M 1.5M
Change In Prepaid Assets 583,000 -225,000 159,000 -- 266,000
Depreciation -- -- 325,000 -- --
Gain Loss On Investment Securities -523,000 331,000 30,000 -564,000 -271,000
Long Term Debt Payments -85,000 -65,000 -200,000 -109,000 -114,000
Net Business Purchase And Sale 0.00 0.00 -- 0.00 0.00
Net Income From Continuing Operations -1.8M -2.7M -3.7M -6.7M -5.8M
Net Long Term Debt Issuance -85,000 -65,000 -200,000 -109,000 -114,000
Net Other Financing Charges -- -42,000 -- -- -74,000
Net Other Investing Changes -- -- -4,000 -7,000 214,000
Operating Gains Losses -412,000 448,000 116,000 -454,000 -136,000
Pension And Employee Benefit Expense 111,000 117,000 86,000 110,000 135,000
Proceeds From Stock Option Exercised -- -- -- -93,000 -74,000
Sale Of PPE 4,000 1,000 4,000 -- 0.00
NEWS
Loading news...
TRENDING
Loading...